跳至主要内容
临床试验/JPRN-UMIN000014528
JPRN-UMIN000014528已完成未知

Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Patients with Coronary Artery Disease - Switching from Clopidogrel to Prasugrel

Chiba University Hospital0 个研究点目标入组 53 人开始时间: 2014年7月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
53

研究概览

简要总结

The prevalence of HPR and the PRU level were significantly lower on prasugrel maintenance therapy compared with the clopidogrel therapy before and after switching.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with contraindications to prasugrel 2. Patients who have severe liver problem 3. Patients who have severe kidney problem 4. Weigh 50 kg or less 5. low platelet counts (less than 10*10^4) 6. Pregnant 7. Patients who are taking anticoagulants 8. Patients who are planned to administer thrombolytic agents 9. Patients scheduled for PCI or coronary artery bypass graft during this study 10. Patients who are taking ticlopidine or cilostazol 11. Patients judged as inappropriate for trial entry

研究者

相似试验